Miguel Ângelo Martins Moreira

Suggest Changes
Learn More
In spite of the effectiveness of Imatinib for chronic myeloid leukemia (CML) treatment, resistance has repeatedly been reported and is associated with point mutations in the BCR-ABL chimeric gene. To(More)